Proti společnosti Dun & Bradstreet byla podána hromadná žaloba kvůli údajným zavádějícím informacím o jejím převzetí přidruženými společnostmi Clearlake Capital Group za 9,15 USD za akcii.
, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Dun & Bradstreet Holdings, Inc. ("Dun & Bradstreet" or the "Company") (NYSE: DNB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether Dun & Bradstreet and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until November 10, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Dun & Bradstreet securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
[Click here for information about joining the class action]
On or about March 23, 2025, Dun & Bradstreet agreed to be acquired by affiliates of Clearlake Capital Group, L.P. ("Clearlake") for $9.15 per share in cash. To obtain the stockholder approval required to consummate the merger, Dun & Bradstreet issued a definitive proxy statement on Schedule 14A on May 13, 2025 (the "Proxy"). Dun & Bradstreet stockholders voted to approve the merger on June 12, 2025, and the merger closed on August 26, 2025.
A complaint has been filed alleging that defendants made false and/or misleading statements and/or failed to disclose material facts in Dun & Bradstreet's March 23, 2025 merger announcement and in the Proxy. The complaint alleges, among other things, that the Proxy and other solicitation materials misled investors regarding the true value of Dun & Bradstreet and the merger, including portraying the merger as the product of an ordinary-course strategic review and organic arm's-length interest in Dun & Bradstreet, while omitting Executive Chairman William P. Foley II's personal interest in a quick sale. The complaint further alleges that the Proxy omitted Bank of America Securities' valuations of superior alternatives to a whole-company sale, misstated that Dun & Bradstreet's Board of Directors had approved downward revisions to Dun & Bradstreet's financial projections, and failed to disclose long-standing, material ties between Foley and Dun & Bradstreet's financial and legal advisors.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
SAN DIEGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of sellers of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) common stock between May 13, 2025 and August 26, 2025, inclusive (the “Class Period”), including holders who exchanged shares of Dun & Bradstreet common stock in the Merger with Clearlake Capital Group, L.P., and holders of Dun & Bradstreet common stock as of the May 9, 2025 record date for the special meeting of stockholders and whose shares were voted on, or entitled to vote on, the merger with Clearlake. Dun & Bradstreet is a global provider of business decision data and analytics.
The complaint alleges that Dun & Bradstreet's sale was engineered by the Company's Executive Chairman William P. Foley to relieve an acute liquidity crisis at Cannae Holdings, Inc., D&B’s largest stockholder, which Foley also chaired—and to defeat an activist proxy contest that threatened Foley’s control of Cannae.
Investors who suffered significant losses during the Class Period may be eligible to participate in the lawsuit and should contact Robbins LLP before the November 10, 2026, lead plaintiff deadline.
Listen to our podcast.
Why Was Dun & Bradstreet Sued?
According to the complaint, on or about March 23, 2025, Dun & Bradstreet agreed to be acquired by affiliates of Clearlake for $9.15 per share in cash. According to the complaint, to obtain the stockholder approval required to consummate the merger, Dun & Bradstreet issued a definitive proxy statement on Schedule 14A on May 13, 2025 (the “Proxy”). Dun & Bradstreet stockholders allegedly voted to approve the merger on June 12, 2025, and the merger closed on August 26, 2025.
Plaintiff alleges that defendants made false and/or misleading statements and/or failed to disclose material facts in Dun & Bradstreet's March 23, 2025, merger announcement and in the Proxy.
Specifically, defendants failed to disclose: (i) the actual impetus for the sale: the liquidity crisis and activist threat confronting Cannae, and Foley's determination to convert Dun & Bradstreet, Cannae's largest holding, into cash quickly to address these issues; (ii) that several alternatives to a whole-company sale were worth materially more than $9.15 per share; (iii) the false board approval of the March Projections; and (iv) the advisor conflicts in the sales process.
Who May Be Eligible to Participate in the Dun & Bradstreet Class Action?
The lawsuit seeks to represent investors who sold Dun & Bradstreet Holdings, Inc. common stock between May 13, 2025 and August 26, 2025. Investors who suffered losses during that period may have legal rights under the federal securities laws.
What Is a Lead Plaintiff?
The lead plaintiff is a court-appointed investor who represents the interests of all class members throughout the litigation. Stockholders who wish to lead the class action should contact Robbins LLP for information prior to the November 10, 2026, lead plaintiff deadline.
Serving as lead plaintiff is not required to share in any potential recovery. Investors who do not seek appointment may remain absent class members if the case proceeds and later resolves successfully.
Does It Cost Anything to Participate?
No. Robbins LLP represents investors on a contingency fee basis.
Contact Robbins LLP
Investors seeking additional information about the Dun & Bradstreet Holdings, Inc. securities class action may contact Robbins LLP by submitting an inquiry, emailing attorney Aaron Dumas, Jr., or calling (800) 350-6003.
Why Robbins LLP?
A recognized leader in shareholder rights litigation, Robbins LLP represents investors in securities fraud and shareholder derivative litigation. We have helped restore more than $2 billion in value to shareholders and secured some of the largest recoveries in shareholder derivative litigation history.
"Companies have an obligation to provide investors with complete and accurate information so that markets can function fairly and efficiently," said Brian J. Robbins, Founding Partner of Robbins LLP.
To be notified if a class action against Dun & Bradstreet Holdings, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
Proti společnosti Dun & Bradstreet byla podána hromadná žaloba kvůli údajným zavádějícím informacím o akvizici společností Clearlake Capital za 9,15 USD za akcii.
WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that: (a) sold shares of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) (“D&B”) common stock in the open market from May 13, 2025 through August 26, 2025; (b) exchanged shares of D&B common stock into the August 26, 2025 merger of D&B with affiliates of Clearlake Capital Group, L.P. for $9.15 per share in cash (the “Merger”); and/or (c) held shares of D&B common stock as of the May 9, 2025 Record Date for the special meeting of stockholders and whose shares were voted on, or entitled to vote on, the Merger, of the important November 10, 2026 lead plaintiff deadline.
SO WHAT: If you sold Dun & Bradstreet common stock, held shares of D&B common stock on May 9, 2025, or exchanged shares of D&B common stock as a result of its merger, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Dun & Bradstreet class action, go to https://rosenlegal.com/cases/dun-bradstreet-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: The lawsuit seeks to recover damages on behalf of investors that were damaged as a result of allegedly false and misleading statements and omissions of material facts in D&B’s March 23, 2025 announcement of the Merger and the May 13, 2025 definitive proxy statement on Schedule 14A (the “Proxy”). Among other things, the complaint alleges the Proxy and other solicitation materials misled investors regarding the true value of D&B and the subject transaction, including portraying the Merger as the product of an ordinary-course strategic review and organic arm’s-length interest in D&B, while omitting Executive Chairman Foley’s personal interest in a quick sale. The complaint also alleges the Proxy omitted Bank of America Securities’ valuations of superior alternatives to a whole-company sale, misstated that D&B’s Board of Directors had approved downward revisions to D&B’s financial projections and failed to disclose long-standing, material ties between Foley and D&B’s financial and legal advisors.
To join the Dun & Bradstreet class action, go to https://rosenlegal.com/cases/dun-bradstreet-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
Proti společnosti Dun & Bradstreet byla podána hromadná žaloba kvůli údajným zavádějícím informacím v souvislosti s akvizicí přidruženými společnostmi Clearlake za 9,15 USD za akcii.
, /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of sellers of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) common stock between May 13, 2025 and August 26, 2025, inclusive (the "Class Period"), including holders who exchanged shares of Dun & Bradstreet common stock in the Merger with Clearlake Capital Group, L.P., and holders of Dun & Bradstreet common stock as of the May 9, 2025 record date for the special meeting of stockholders and whose shares were voted on, or entitled to vote on, the merger with Clearlake. Dun & Bradstreet is a global provider of business decision data and analytics.
The complaint alleges that Dun & Bradstreet's sale was engineered by the Company's Executive Chairman William P. Foley to relieve an acute liquidity crisis at Cannae Holdings, Inc., D&B's largest stockholder, which Foley also chaired—and to defeat an activist proxy contest that threatened Foley's control of Cannae.
Investors who suffered significant losses during the Class Period may be eligible to participate in the lawsuit and should contact Robbins LLP before the November 10, 2026, lead plaintiff deadline.
Listen to our podcast.
Why Was Dun & Bradstreet Sued?
According to the complaint, on or about March 23, 2025, Dun & Bradstreet agreed to be acquired by affiliates of Clearlake for $9.15 per share in cash. According to the complaint, to obtain the stockholder approval required to consummate the merger, Dun & Bradstreet issued a definitive proxy statement on Schedule 14A on May 13, 2025 (the "Proxy"). Dun & Bradstreet stockholders allegedly voted to approve the merger on June 12, 2025, and the merger closed on August 26, 2025.
Plaintiff alleges that defendants made false and/or misleading statements and/or failed to disclose material facts in Dun & Bradstreet's March 23, 2025, merger announcement and in the Proxy.
Specifically, defendants failed to disclose: (i) the actual impetus for the sale: the liquidity crisis and activist threat confronting Cannae, and Foley's determination to convert Dun & Bradstreet, Cannae's largest holding, into cash quickly to address these issues; (ii) that several alternatives to a whole-company sale were worth materially more than $9.15 per share; (iii) the false board approval of the March Projections; and (iv) the advisor conflicts in the sales process.
Who May Be Eligible to Participate in the Dun & Bradstreet Class Action?
The lawsuit seeks to represent investors who sold Dun & Bradstreet Holdings, Inc. common stock between May 13, 2025 and August 26, 2025. Investors who suffered losses during that period may have legal rights under the federal securities laws.
What Is a Lead Plaintiff?
The lead plaintiff is a court-appointed investor who represents the interests of all class members throughout the litigation. Stockholders who wish to lead the class action should contact Robbins LLP for information prior to the November 10, 2026, lead plaintiff deadline.
Serving as lead plaintiff is not required to share in any potential recovery. Investors who do not seek appointment may remain absent class members if the case proceeds and later resolves successfully.
Does It Cost Anything to Participate?
No. Robbins LLP represents investors on a contingency fee basis.
Contact Robbins LLP
Investors seeking additional information about the Dun & Bradstreet Holdings, Inc. securities class action may contact Robbins LLP by submitting an inquiry, emailing attorney Aaron Dumas, Jr., or calling (800) 350-6003.
Why Robbins LLP?
A recognized leader in shareholder rights litigation, Robbins LLP represents investors in securities fraud and shareholder derivative litigation. We have helped restore more than $2 billion in value to shareholders and secured some of the largest recoveries in shareholder derivative litigation history.
"Companies have an obligation to provide investors with complete and accurate information so that markets can function fairly and efficiently," said Brian J. Robbins, Founding Partner of Robbins LLP.
To be notified if a class action against Dun & Bradstreet Holdings, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
Proti společnosti Dun & Bradstreet byla podána hromadná žaloba kvůli údajným zavádějícím informacím o akvizici společností Clearlake Capital za 9,15 USD za akcii.
New York, New York--(Newsfile Corp. - October 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that: (a) sold shares of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) ("D&B") common stock in the open market from May 13, 2025 through August 26, 2025; (b) exchanged shares of D&B common stock into the August 26, 2025 merger of D&B with affiliates of Clearlake Capital Group, L.P. for $9.15 per share in cash (the "Merger"); and/or (c) held shares of D&B common stock as of the May 9, 2025 Record Date for the special meeting of stockholders and whose shares were voted on, or entitled to vote on, the Merger, of the important November 10, 2026 lead plaintiff deadline.
SO WHAT: If you sold Dun & Bradstreet common stock, held shares of D&B common stock on May 9, 2025, or exchanged shares of D&B common stock as a result of its merger, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Dun & Bradstreet class action, go to https://rosenlegal.com/cases/dun-bradstreet-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: The lawsuit seeks to recover damages on behalf of investors that were damaged as a result of allegedly false and misleading statements and omissions of material facts in D&B's March 23, 2025 announcement of the Merger and the May 13, 2025 definitive proxy statement on Schedule 14A (the "Proxy"). Among other things, the complaint alleges the Proxy and other solicitation materials misled investors regarding the true value of D&B and the subject transaction, including portraying the Merger as the product of an ordinary-course strategic review and organic arm's-length interest in D&B, while omitting Executive Chairman Foley's personal interest in a quick sale. The complaint also alleges the Proxy omitted Bank of America Securities' valuations of superior alternatives to a whole-company sale, misstated that D&B's Board of Directors had approved downward revisions to D&B's financial projections and failed to disclose long-standing, material ties between Foley and D&B's financial and legal advisors.
To join the Dun & Bradstreet class action, go to https://rosenlegal.com/cases/dun-bradstreet-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/318345
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that: (a) sold shares of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) (“D&B”) common stock in the open market from May 13, 2025 through August 26, 2025; (b) exchanged shares of D&B common stock into the August 26, 2025 merger of D&B with affiliates of Clearlake Capital Group, L.P. for $9.15 per share in cash (the “Merger”); and/or (c) held shares of D&B common stock as of the May 9, 2025 Record Date for the special meeting of stockholders and whose shares were voted on, or entitled to vote on, the Merger, of the important November 10, 2026 lead plaintiff deadline.
SO WHAT: If you sold Dun & Bradstreet common stock, held shares of D&B common stock on May 9, 2025, or exchanged shares of D&B common stock as a result of its merger, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Dun & Bradstreet class action, go to https://rosenlegal.com/cases/dun-bradstreet-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: The lawsuit seeks to recover damages on behalf of investors that were damaged as a result of allegedly false and misleading statements and omissions of material facts in D&B’s March 23, 2025 announcement of the Merger and the May 13, 2025 definitive proxy statement on Schedule 14A (the “Proxy”). Among other things, the complaint alleges the Proxy and other solicitation materials misled investors regarding the true value of D&B and the subject transaction, including portraying the Merger as the product of an ordinary-course strategic review and organic arm’s-length interest in D&B, while omitting Executive Chairman Foley’s personal interest in a quick sale. The complaint also alleges the Proxy omitted Bank of America Securities’ valuations of superior alternatives to a whole-company sale, misstated that D&B’s Board of Directors had approved downward revisions to D&B’s financial projections and failed to disclose long-standing, material ties between Foley and D&B’s financial and legal advisors.
To join the Dun & Bradstreet class action, go to https://rosenlegal.com/cases/dun-bradstreet-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
